| Hans-Günter Meyer-Thompson | International
USA. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care - New Rules Expand Telehealth Options for Opioid Use Disorder and Veterans’ Treatments
USA. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care - New Rules Expand Telehealth Options for Opioid Use Disorder and Veterans’ Treatments
WASHINGTON – The U.S. Drug Enforcement Administration, in partnership with the Department of Health and Human Services (HHS), has issued a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the Prescription of Controlled Medications, extending the current telemedicine flexibilities through December 31, 2026. (DEA – Drug Enforcement Administration, USA, 31.12.2025)